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The European Union Directive on the application of patients’ rights incross-border healthcare 
Over the last decade, the European Court of Justice (ECJ) has con-
firmed the responsibilities of European Union (EU) Member States in
the health care sector. It has also underlined the right for patient
mobility outside national borders in order to access health care servic-
es in other countries. 
Furthermore, the ECJ, in the leading case Leichtle has stated the fol-
lowing:
- prior authorisation must be regarded as a hindrance that prevents
patient mobility to other countries;
- there is no need for a scientific test that proves that thermal spa
treatment is better at home rather than abroad;
- the thermal spa centres and establishments abroad must be recog-
nised by the national health service concerned and appropriately
registered within it.
The above-mentioned statements of the ECJ have been integrated
into the EU Directive no. 24/2011/CE of 9th March 2011 concerning the
application of patients’ rights in cross-border healthcare. This
Directive represents a very important and strategic piece of European
legislation. It is especially important because it has actually replaced
the prior authorisation procedures that were previously required to
allow patients to go abroad to access health care services. Therefore,
in this respect, the Directive has contributed to improving the level of
freedom of choice for the European citizens.
Moreover, the strategic importance of the Directive must be recog-
nised since it could potentially develop towards allowing EU citizens to
move cross-border confident that the costs that they incur for services
from another health care system are to be paid by their State of affili-
ation. 
The Directive strikes a balance between the citizens’ rights to move
freely across borders to access health care services and the need for
the Member States to control their health budgets. Accordingly,
finance restrictions versus freedom of choice seems to be the battle
that nowadays health care systems are called upon to engage in. Does
this mean then that the patient’s right to access health care services
depends on the budgets of the Member States? Are we facing a time in
which the principle that defines many legal systems, especially those
in Europe, according to which everyone is entitled to access health care
services regardless of wealth is about to give way to financial sustain-
ability? On reading the recent decision taken by the Indian Supreme
Court on 1st April 2013 regarding Novartis International AG, one could
presume that health comes first. Indeed, the Indian judges have stated
that medicines are to help as many people as possible, and hence
patents are not to be authorised when a non-patent pharmaceutical
product can be invented anyhow. This is not actually the appropriate
place whereby to deepen the legal implications of the denial of patents
in the pharmaceutical sector. It is, however, possible to make some
short comments on the decision. Firstly, the Indian judges have sup-
ported the idea that the right to health, as, for example, it is effective-
ly described in the Italian Constitution of 1948, is a right to which any
person should be entitled. Accordingly, public health should be separat-
ed from people’s specific economic and financial conditions. Secondly,
the decision held by the Indian Supreme Court seems to open up
another issue, namely, the investments that the health care system
needs. In other words, translating the decision into the European con-
text, we might point out that the European Union at large and the
Member States individually are called upon to establish their priorities
for action. The health care systems are often regarded only as expen-
sive pieces of the modern welfare states that need to be reduced in
order to ensure financial sustainability. There is evidence that reduc-
ing costs and making savings should be one of the goals of health care
sector. But these should also recognise the top priority that is to be
identified in the protection of the citizen’s right to access health care
services. We would like to think of a health care system as one in
which financial resources and priorities of actions are bound together.
We would not like to think of a health care system in which financial
resources influence the decision-making process or policy making. 
In other words, there should be still some room for health care sys-
tems to shift their focus from the assumption that, first and foremost,
it is fundamental to protect citizens’ welfare and wellbeing. 
In this respect, particular attention should be devoted to the legal
and organisational systems provided for the health care services.
Indeed, there is a direct link between the citizen’s right to access
health care services and the way these services are provided. And this
is especially clear in those legal systems in which the central govern-
ment has long ceased to play the pivotal role that it had previously had.
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